Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.08T | 30x | 1.59 | SEK 1,344.50 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.3% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 90.94B | 23.2x | 0.43 | SEK 266.40 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.3% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 33.42B | 77.3x | -18.62 | SEK 570 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.4% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 21.01B | 155.6x | -3.1 | SEK 318.80 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.4% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 19.86B | 100.6x | 1.12 | SEK 39.06 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.33B | 29.3x | -7.25 | SEK 101.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 5.87B | 59.3x | 0.83 | SEK 36.65 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.22B | -12.7x | -0.19 | SEK 41.10 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 801.03M | -11.8x | -1.75 | SEK 3.25 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21% Downside | Upgrade to Pro+ | |
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 683M | -5x | 2.61 | SEK 50.30 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 558.04M | 51.7x | -0.96 | SEK 28.60 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cinclus Pharma Holding AB | Stockholm | Healthcare | Pharmaceuticals | SEK 497.95M | -3.4x | -0.07 | SEK 10.20 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 491.83M | -5.3x | -0.23 | SEK 0.29 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 472.72M | -2.4x | 0.04 | SEK 14.70 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.4% Upside | Upgrade to Pro+ | |
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 377.08M | -4.6x | -0.08 | SEK 7.27 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 369.34M | -1.2x | 0 | SEK 7.87 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.4% Upside | Upgrade to Pro+ | |
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 302.28M | -4.6x | -0.23 | SEK 15 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 288.95M | -6.6x | 0.38 | SEK 1.79 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 232.17M | -8.9x | 0.01 | SEK 9.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 213.70M | -11.2x | -0.18 | SEK 12.80 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 213.11M | -7.8x | -0.16 | SEK 0.25 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 157.74M | -6x | -0.24 | SEK 3.35 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | |
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 134.86M | -2.7x | -0.06 | SEK 2.23 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 125.36M | -3.3x | -0.05 | SEK 0.23 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 82.74M | -6.9x | -1.19 | SEK 3.45 | 13.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XP Chemistries AB | Stockholm | Healthcare | Pharmaceuticals | SEK 61.26M | -5x | -0.13 | SEK 0.24 | -22.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 59.62M | -8.5x | -0.15 | SEK 4.92 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 52.05M | -0.9x | -0.02 | SEK 19.58 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 42.65M | -9.3x | 9.23 | SEK 2.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Double Bond Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 35.99M | -2.6x | -0.08 | SEK 0.34 | 23.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
QuiaPEG Pharmaceutical | Stockholm | Healthcare | Pharmaceuticals | SEK 20.54M | -0.4x | -0.01 | SEK 0.01 | -24.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipigon Pharmaceuticals AB | Stockholm | Healthcare | Pharmaceuticals | SEK 18.84M | -0.6x | -0.21 | SEK 0.12 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |